Cathay Biotech Inc. (SHA:688065)
China · Delayed Price · Currency is CNY 49.65
+0.70 (1.43%)
Aug 6, 2025, 2:45 PM CST
Verve Therapeutics Market Cap
Cathay Biotech has a market cap or net worth of 35.74 billion as of August 6, 2025. Its market cap has increased by 44.85% in one year.
Market Cap
35.74B
Enterprise Value
30.16B
Revenue
3.05B
Ranking
n/a
PE Ratio
55.71
Stock Price
$49.65
Market Cap Chart
Since August 12, 2020, Cathay Biotech's market cap has decreased from 65.42B to 35.74B, a decrease of -45.36%. That is a compound annual growth rate of -11.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 35.74B | 58.48% |
| Dec 31, 2024 | 22.56B | -29.54% |
| Dec 29, 2023 | 32.01B | -10.45% |
| Dec 30, 2022 | 35.75B | -53.44% |
| Dec 31, 2021 | 76.79B | 116.67% |
| Dec 31, 2020 | 35.44B | -45.83% |
| Aug 12, 2020 | 65.42B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wanhua Chemical Group | 189.33B |
| Baoshan Iron & Steel | 158.08B |
| Shandong Gold Mining | 134.95B |
| China Northern Rare Earth (Group) High-Tech Co.,Ltd | 131.23B |
| Ningxia Baofeng Energy Group | 113.96B |
| Inner Mongolia Baotou Steel Union | 113.67B |
| Hengli Petrochemical | 107.42B |
| Qinghai Salt Lake Industry Co.,Ltd | 95.94B |